'Not A Cure,' But Cambridge Biotech's Gene Therapy Gets Teen With Sickle Cell Off Meds
"It shows gene therapy is on the right track. Gene therapy offers hope of a lasting one. A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of the disorder, researchers report. Full results have not been reported, but the gene therapy has not taken hold as well in some of them as it did in the French teen. About 90,000 people in the U.S., mostly blacks, have sickle cell, the first disease for which a molecular cause was found.Sickle cell disease is one that mainly affects people of African, Caribbean, Middle Eastern, Eastern Mediterranean, and Asian origin. Fifteen months later, the boy, now 15, is not suffering from any of the effects of sickle cell disease. The afflicted have unusually shaped (sickle) blood cells thanks to a coding error in the gene for hemoglobin, the oxygen-carrying segment of red blood cells. Now, the same type of process has been used to cancel out all the symptoms of a French teenager's sickle cell disease. Sickle cells in among normal blood cells.
collected by :Lucy William
No comments:
Post a Comment